Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Revealing the Hidden Impact: Family Spillover E...
By
Thanusha Pillay
July 29, 2024
Introduction Cost-utility analysis (CUA) is increasingly used in healthcare decision-making for funding, reimbursement, and pricing of new interventions. Health Technology Assessment (HTA) agenci...
Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Imp...
Antenatal HCV Screening in Egypt: Paving the Path to Elimination
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...
Impact of Brain Cancer Care Coordinators on Healthcare Utilisation
Rare Diseases: Modern Strategies for Enhanced Primary Care
Challenges and Opportunities in Educating the Public About Childhood Arthriti...
Access to Essential Medicines for Rheumatic Diseases in Children
Paediatric Rheumatology Care in Africa: Hope and Resilience
Economic Burden of Juvenile Idiopathic Arthritis in Spain
Juvenile Arthritis: Meeting the Benchmark with Health Technology
« Previous
1
…
26
27
28
29
30
…
44
Next »